0
Article Tier 2 Sign in to save

Microplastics and nanoplastics as potential ecological oncogenic co-drivers: rewiring host–microbe interactions in cancer

AI summary Read the abstract

This review paper summarizes existing research proposing that tiny plastic particles called microplastics and nanoplastics may disrupt the gut lining, immune responses, and gut bacteria in ways that could contribute to cancer development. The authors note this is a conceptual framework based on lab and biomarker evidence, with direct human data still limited.

Body Systems

Microplastics and nanoplastics (MPs/NPs) are increasingly recognized as biologically active interfaces that may reshape host–microbe interactions in carcinogenesis. This review proposes a hypothesis-generating mechanistic framework in which MPs/NPs may influence cancer-related processes through the integration of environmental exposure, epithelial barrier disruption, immune dysregulation, and tumor microenvironment remodeling. Although applicable to multiple epithelial interfaces, the framework primarily focuses on the intestinal mucosa, where the most substantial evidence exists. Through plastisphere formation, MPs/NPs adsorb pollutants, virulence factors, and microbial communities, potentially facilitating pathogen persistence, horizontal gene transfer, and antibiotic resistance enrichment. Upon host exposure, MPs/NPs have been associated with compromised epithelial integrity, enhanced microbial translocation, and activation of inflammatory pathways involving pattern recognition receptors, NF-κB, and the NLRP3 inflammasome. At the microbiome level, MPs/NPs may promote dysbiosis, alter microbial metabolism, and favor pro-inflammatory and genotoxic metabolites that could reinforce oncogenic signaling. These processes may converge to sustain chronic inflammation, immune evasion, extracellular matrix remodeling, angiogenesis, and tumor-permissive niches. While experimental and biomarker-based evidence support this axis, direct human data remain limited. Collectively, this review provides a conceptual basis for understanding environmentally associated carcinogenesis through MPs/NPs as ecological mediators bridging the environmental exposures, microbiome, and cancer biology.

More Papers Like This

Article Tier 2

Microplastics: An emerging environmental risk factor for gut microbiota dysbiosis and cancer development?

AI summary Read the abstract

This review examines how microplastics may disrupt the gut microbiome and immune system in ways that could promote cancer development. Evidence from recent studies suggests microplastics can cause chronic inflammation, alter the balance of gut bacteria, and trigger molecular pathways linked to several cancer types including lung, liver, breast, and colon cancer. While more human research is needed, the review highlights a concerning connection between microplastic exposure, gut health, and cancer risk.

Article Tier 2

Microplastics and gut dysbiosis: links to cancer inflammation

AI summary Read the abstract

This review summarizes existing research on how tiny plastic particles called microplastics may disrupt gut bacteria and the gut's protective lining. The studies suggest these changes are linked to inflammation and may be connected to cancer progression and weaker responses to cancer treatments, though more research in humans is needed.

Article Tier 2

Microplastics as emerging carcinogens: from environmental pollutants to oncogenic drivers

AI summary Read the abstract

This review examines growing evidence that microplastics and nanoplastics may play a role in cancer development, with these particles found in human tumor tissues from the lungs, colon, stomach, breast, and other organs. The particles appear to promote cancer through chronic inflammation, oxidative stress, DNA damage, and disruption of key cancer-related signaling pathways. While direct proof of causation in humans is still lacking, the accumulating evidence from lab studies, animal experiments, and human tissue analysis suggests microplastics deserve serious attention as potential contributors to cancer risk.

Article Tier 2

Microplastic-induced carcinogenesis: Molecular mechanisms, cellular interactions, and toxicological implications

AI summary Read the abstract

Tiny plastic particles that we breathe, eat, and touch every day are now showing up in our blood, lungs, and other organs, and this review of existing research explains how they might contribute to cancer. Microplastics can trigger cell damage, inflammation, and disrupted signaling in ways linked to tumor growth, and they can also act like tiny rafts that ferry other harmful chemicals and toxins deeper into our bodies. While scientists haven't proven microplastics directly cause cancer in humans yet, the mounting evidence is a strong signal that reducing plastic exposure and pushing for more research should be a public health pri

Article Tier 2

Microplastics: an often-overlooked issue in the transition from chronic inflammation to cancer

AI summary Read the abstract

This review explores how microplastics that accumulate in the human body may trigger long-lasting inflammation, which is a known driver of cancer development. The authors describe how microplastics can disrupt the gut microbiome, activate immune responses, and alter signaling pathways in ways that could promote tumor growth over time.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper